Analyst Consensus ?
ConsensusBuy23 ratings
Bullish1773.9%
Neutral521.7%
Bearish14.4%
Rocket Lab USA, Inc. · RKLB · FY2026 Q3 · Calendar Q4 2026
Rocket Lab Q3: Revenue Beat, EPS Loss Wider Than Expected
Q3 results were mixed: revenue exceeded consensus while the loss per share was wider than consensus. The top-line result is evidence of revenue resilience, but the supplied current-call analysis does not establish how management views the outlook or the path to improved profitability.
Why did RKLB fall 1.0% after missing EPS estimates in FY2026 Q3?
Research this report with FN2. Free to start; review your question before sending.
Reported After market closeNASDAQIndustrials
$35.23B market cap
75quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$-0.12
Consensus $-0.07
EPS surprise
-79.5%
Reported versus consensus
Reported revenue
$267.8M
Consensus $257.2M
Revenue surprise
+4.1%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-1.0%
Event window
SPY move
-0.6%
Same window
Abnormal move
-0.4%
Stock minus SPY
Volume
0.4×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
RKLBSPY benchmark
Ask FN2 about RKLB FY2026 Q3
Choose a question to continue your research
Why did RKLB fall 1.0% after missing EPS estimates in FY2026 Q3?What changed in RKLB's guidance and outlook in FY2026 Q3?Give me the bull and bear case for RKLB after FY2026 Q3 earnings.
Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Q3 revenue was above consensus, while reported EPS was a larger loss than consensus. No current-quarter transcript analysis was supplied, so management commentary and any change in outlook cannot be assessed against the prior quarter.
Guidance delta
No current-quarter guidance analysis is available in the supplied materials. The prior-quarter analysis described guidance sentiment as maintained; there is no basis here to identify a new guidance direction.
Key takeaways
- Revenue exceeded consensus; EPS missed consensus with a wider-than-expected loss.
- The supplied current-quarter transcript analysis is empty, limiting conclusions about management's commentary and outlook.
- The prior-quarter analysis highlighted Neutron development, Space Systems growth, and the proposed Iridium acquisition; this run does not establish whether those priorities changed.
Management priorities
- Prior-quarter analysis identified Neutron development and scaling as a priority.
- Prior-quarter analysis identified expansion of Space Systems and satellite-component production as priorities.
- Prior-quarter analysis described the pending Iridium acquisition and integrated services as a strategic priority; no current-quarter update was available.
Follow RKLB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$66.14Current
$4.5Low
$80.3Average
$135High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 11, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Piper Sandler | Neutral | Neutral | Maintain | Nov 10, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Nov 10, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Nov 10, 2026 |
| BTIG | Neutral | Neutral | Maintain | Nov 10, 2026 |
| Barclays | Overweight | Overweight | Maintain | Nov 10, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Oct 16, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 15, 2026 |
| B of A Securities | Buy | Buy | Maintain | Aug 31, 2026 |
| KGI Securities | Outperform | Neutral | Upgrade | Jul 27, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jun 30, 2026 |
| Needham | Buy | Buy | Maintain | Jun 30, 2026 |
| Craig-Hallum | Buy | Buy | Maintain | Jun 30, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | May 12, 2026 |
| Stifel | Buy | Buy | Maintain | Apr 20, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 20, 2026 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jan 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 8, 2025 |
| Citizens Capital Markets | Market Perform | Market Perform | Maintain | Mar 14, 2025 |
| Roth MKM | Buy | Buy | Maintain | Jun 18, 2024 |
| Credit Suisse | Underperform | Underperform | Maintain | Oct 12, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Aug 31, 2022 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 9, 2021 |
Named analyst price targets
Upside is calculated against the persisted current price $66.14. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Alexander Potter | $58 | $59.26 | -12.3% | Nov 10, 2026 |
| Needham | Ryan Koontz | $120 | $55.25 | +81.4% | Oct 16, 2026 |
| KeyBanc | Analyst unavailable | $100 | $59.18 | +51.2% | Oct 15, 2026 |
| Barclays | Analyst unavailable | $85 | $68.4 | +28.5% | Oct 8, 2026 |
| Raymond James | Brian Gesuale | $80 | $61.96 | +21.0% | Sep 11, 2026 |
| Berenberg Bank | Analyst unavailable | $83 | $62.54 | +25.5% | Sep 2, 2026 |
| Cantor Fitzgerald | Andres Sheppard | $122 | $78.85 | +84.5% | Aug 11, 2026 |
| Roth Capital | Analyst unavailable | $110 | $80.04 | +66.3% | Aug 11, 2026 |
| KGI Securities | Analyst unavailable | $107 | $63.91 | +61.8% | Jul 27, 2026 |
| Piper Sandler | Alexander Potter | $83 | $76.2 | +25.5% | Jul 15, 2026 |
| Roth Capital | Suji Desilva | $130 | $98.01 | +96.6% | Jun 29, 2026 |
| Craig-Hallum | Jeff Van Rhee | $120 | $98.1 | +81.4% | Jun 29, 2026 |
| KeyBanc | Michael Leshock | $135 | $102.39 | +104.1% | Jun 15, 2026 |
| KGI Securities | Analyst unavailable | $105 | $105.05 | +58.8% | Jun 11, 2026 |
| Stifel Nicolaus | Erik Rasmussen | $132 | $114.7 | +99.6% | Jun 4, 2026 |
| Deutsche Bank | Analyst unavailable | $120 | $116.16 | +81.4% | May 12, 2026 |
| Craig-Hallum | Analyst unavailable | $98 | $78.58 | +48.2% | May 8, 2026 |
| Stifel Nicolaus | Analyst unavailable | $105 | $87.75 | +58.8% | Apr 20, 2026 |
| Roth Capital | Analyst unavailable | $100 | $82.93 | +51.2% | Apr 17, 2026 |
| Cantor Fitzgerald | Andres Sheppard | $85 | $68.37 | +28.5% | Mar 13, 2026 |
| Goldman Sachs | Anthony Valentini | $69 | $96.3 | +4.3% | Jan 20, 2026 |
| Morgan Stanley | Kristine Liwag | $105 | $90.76 | +58.8% | Jan 16, 2026 |
| Needham | Ryan Koontz | $90 | $77.55 | +36.1% | Dec 23, 2025 |
| Stifel Nicolaus | Analyst unavailable | $85 | $70.52 | +28.5% | Dec 22, 2025 |
| Needham | Ryan Koontz | $63 | $54.98 | -4.7% | Nov 12, 2025 |
| Roth Capital | Suji Desilva | $75 | $51.9 | +13.4% | Nov 11, 2025 |
| Stifel Nicolaus | Erik Rasmussen | $75 | $51.9 | +13.4% | Nov 11, 2025 |
| KeyBanc | Analyst unavailable | $75 | $67 | +13.4% | Oct 17, 2025 |
| Robert W. Baird | Peter Arment | $83 | $69.27 | +25.5% | Oct 15, 2025 |
| Cantor Fitzgerald | Andres Sheppard | $35 | $42.34 | -47.1% | Jul 14, 2025 |
| Stifel Nicolaus | Erik Rasmussen | $31 | $27.95 | -53.1% | Jan 8, 2025 |
| KeyBanc | Mike Leschock | $12 | $10.91 | -81.9% | Oct 23, 2024 |
| KeyBanc | Mike Leschock | $11 | $8.69 | -83.4% | Sep 27, 2024 |
| Morgan Stanley | Kristine Liwag | $6 | $5.65 | -90.9% | Jul 15, 2024 |
| Goldman Sachs | Noah Poponak | $4.5 | $4.56 | -93.2% | Jun 11, 2024 |
| Stifel Nicolaus | Erik Rasmussen | $9 | $3.76 | -86.4% | May 7, 2024 |
| Citigroup | Jason Gursky | $6 | $4.66 | -90.9% | Feb 12, 2024 |
| KeyBanc | Michael Leshock | $8 | $4.92 | -87.9% | Jan 17, 2024 |
| Stifel Nicolaus | Erik Rasmussen | $10 | $4.3 | -84.9% | Sep 27, 2023 |
| Deutsche Bank | Analyst unavailable | $12 | $5.36 | -81.9% | Nov 14, 2022 |
| Morgan Stanley | Analyst unavailable | $10 | $5.63 | -84.9% | Nov 11, 2022 |
| Cowen & Co. | Sam Boughedda | $8 | $5.52 | -87.9% | Aug 31, 2022 |
| Stifel Nicolaus | Analyst unavailable | $15 | $5.99 | -77.3% | Aug 17, 2022 |
| Deutsche Bank | Analyst unavailable | $15 | $6.94 | -77.3% | Aug 15, 2022 |
| Wells Fargo | Matthew Akers | $5 | $4.2 | -92.4% | Jun 21, 2022 |
| Deutsche Bank | Analyst unavailable | $14 | $5.66 | -78.8% | May 17, 2022 |
Track every rating change on RKLB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationHeadquartered in Long Beach, California, Rocket Lab USA, Inc. is a prominent aerospace firm established in 2006. This company delivers a comprehensive suite of space-related services and hardware, primarily catering to the space and defense industries. Their operations encompass orbital launch capabilities, advanced spacecraft engineering and construction, production of various spacecraft components, and sophisticated on-orbit management services, including full constellation management. Rocket Lab is known for developing and producing a range of launch vehicles, from small to medium-class rockets.…
Historical context
All RKLB earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| TDG TransDigm Group Incorporated | FY2026 Q4 · Calendar Q4 2026 | +1.9% | +0.5% | TransDigm closes FY2026 with broad growth and sets a higher-investment FY2027 outlook |
| EMBJ Embraer S.A. | FY2026 Q3 · Calendar Q4 2026 | -49.4% | +7.0% | Embraer’s record Q3 and raised outlook meet a sharp EPS miss |
| CNH CNH Industrial N.V. | FY2026 Q3 · Calendar Q4 2026 | +67.1% | +10.9% | CNH sharpens agriculture focus as margins improve and construction JV advances |
| FERG Ferguson Enterprises Inc. | FY2026 Q3 · Calendar Q4 2026 | +3.6% | +11.2% | Ferguson raises FY2026 outlook as industrial and HVAC sales accelerate |
| RBA RB Global, Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.0% | +2.4% | RB Global raises FY2026 outlook as Q3 GTV and adjusted EBITDA grow |
Latest beats and misses
Who reports nextBeat on EPS
- VGFY2026 Q3 · November 10, 2026+92.7% EPS+1.7% move
- TDGFY2026 Q4 · November 10, 2026+1.9% EPS+0.5% move
- ONONFY2026 Q3 · November 10, 2026+39.9% EPS-7.5% move
- CRWVFY2026 Q3 · November 10, 20260.0% EPS-0.5% move
- OXYFY2026 Q3 · November 9, 2026+30.8% EPS+2.0% move
- MGREFY2026 Q3 · November 9, 2026+8.1% EPS+0.6% move
Missed on EPS
- EMBJFY2026 Q3 · November 10, 2026-49.4% EPS+7.0% move
- VODFY2027 Q2 · November 10, 2026-72.8% EPS-1.2% move
- SEFY2026 Q3 · November 10, 2026-5.1% EPS-1.5% move
- BAPFY2026 Q3 · November 9, 2026-2.6% EPS+3.3% move
- JBSFY2026 Q3 · November 9, 2026-28.6% EPS-5.5% move
- CIBFY2026 Q3 · November 9, 2026-10.1% EPS-4.0% move
Get the RKLB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-10T15:10:27.094240+00:00
- FN2 earnings calendar · 2026-11-10T01:23:14.443147+00:00
- Polygon adjusted daily market bars · 2026-11-10T15:10:51.206652+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-10T15:10:51.203982+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-10. For educational purposes only; not investment advice.